Overall study design

KH Kyra Henderson
JR Jennifer Reihm
KK Kanishka Koshal
JW Jaeleene Wijangco
NM Nicolette Miller
NS Narender Sara
MD Marianne Doyle
AM Alicia Mallory
JS Judith Sheridan
CG Chu-Yueh Guo
LO Lauren Oommen
AF Anthony Feinstein
CM Christina Mangurian
AL Ann Lazar
RB Riley Bove
request Request a Protocol
ask Ask a question
Favorite

MS CATCH is a phase II 12-month pragmatic clinical treatment trial enrolling diverse PwMS with mild to moderately severe self-reported mood using simple stepped wedge design (figure 2).

Overview of trial design and outcomes. A 12-month, delayed-start, randomised phase II clinical trial evaluating the efficacy (behaviours, mood) and usability of a closed loop tool for comprehensive real-time depression care in MS. HADS-D, Hospital Anxiety Depression Scale-Depression; MS, multiple sclerosis; MS CATCH, Care technology to Ascertain, Treat and engage the Community to Heal depression in patients with MS.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A